- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Loading...
Zydus Lifesciences has extended the acquisition of Sterling Biotech's API business to December 31, 2025, as Sterling completes necessary conditions. This further delays the strategic business development.